US FDA GRANTS EMERGENCY USE AUTHORIZATION TO ELI LILLY'S ANTIBODY COCKTAIL FOR COVID-19

Highlights

• The company has said that the new treatment adds etesevimab or LY-CoV016 to bamlanivab or LY-CoV555, which has already been authorized, in order to make a double-antibody version

• Similar kind of dual antibody-cocktail is already available in the market courtesy of Regeneron

• The authorized use includes treatment for those who are 65 years of age or older or who have certain chronic m....